Overview
Monitlab is a diagnostic laboratory specializing in therapeutic drug monitoring (TDM) for antifungal medications used in oncology, such as posaconazole and busulfan. The company offers both single sample measurements and full pharmacokinetic profiles, providing results within 48 hours of sample receipt. Their laboratory is equipped with advanced technology, including the UltiMate 3000 UHPLC chromatograph, and they collaborate with clinical centers in Poland for monitored therapy.
Financials
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2020-05-22. Active
56 1090 1362 0000 0001 4419 6852
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 1, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Fundacja Uniwersytetu Im. Adama Mickiewicza w Poznaniu | |
| Jan 23, 2020 | Aid for SME access to finance — aid for start-ups | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
Tenders
No recorded participation in tenders.
Public sector contracts
Monitlab is the contractor in one public sector contract, worth PLN 300.00.
| Public buyer | Value | |
|---|---|---|
| Szpital Kliniczny Im. Karola Jonschera Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu | PLN 300.00 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, making declarations of will on behalf of the company requires the joint action of two members of the management board or one member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Diagnostyki Molekularnej Diagmolsp. z o.o. | $203,495.41 | diagmol.pl | ||
| Vita Complexsp. z o.o. | $88,808.63 | vitacomplex.pl | ||
| Anchem Laboratorium Analiz Medycznych Nzozsp. z o.o. | $86,128.28 | anchem.com.pl | ||
| Diagnosteosp. z o.o. | $74,641.64 | diagnosteo.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| TMRWsp. z o.o. | $55,483.98 | tomorrowlabs.pl | ||
| Medtrans999sp. z o.o. | $39,156.15 | medtrans999.pl | ||
| Alldiagnosticasp. z o.o. | $38,980.99 | alldiagnostica.pl | ||
| Cellmedsp. z o.o. | $21,757.80 | cellmed.pl | ||
| Info-Patsp. z o.o. | $10,464.59 | info-pat.poznan.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-27 | PKD change (Removed: 32.50.A, 46.5, 47.4, 62, 63, 77.40.A, 77.40.B; Added: 62.10.B, 62.20.B, 85.69.Z, 86.91.A, 86.91.B, 86.99.D) | |
| 2025-09-19 | Entered in the register |
FAQ
Last updated: 2026-10-13